Administration of Celecoxib for Treatment of Intracerebral Hemorrhage : A Pilot Study

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

August 31, 2009

Conditions
Intracerebral Hemorrhage
Interventions
DRUG

celecoxib medication

In the celecoxib group, patients will take celecoxib 400mg twice (per day), orally for 14 days.

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT00526214 - Administration of Celecoxib for Treatment of Intracerebral Hemorrhage : A Pilot Study | Biotech Hunter | Biotech Hunter